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Abstract
Background: Stroke contributes significantly to disability and mortality in developing countries yet little is known about the
determinants of stroke outcomes in such countries. 12% of Malawian adults have HIV/AIDS. It is not knownwhether having HIV-
infection alters the outcome of stroke. The aim of this study was to document the functional outcome and mortality at 1 year of
first-ever acute stroke in Malawi. Also to find out if the baseline variables, including HIV-infection, affect the outcome of stroke.
Methods and Findings: 147 adult patients with first-ever acute stroke were prospectively followed up for 12 months.
Conventional risk factors and HIV-infection were assessed at baseline. Stroke severity was evaluated with modified National
Institute of Health Stroke Scale (mNIHSS) and functional outcome with modified Rankin scale (mRS). Fifty (34%) of patients
were HIV-seropositive. 53.4% of patients had a poor outcome (severe disability or death, mRS 4–6) at 1 year. Poor outcomewas
related to stroke severity and female gender but not to presence of HIV-infection. HIV-seropositive patients were younger and
had less often common risk factors for stroke. They suffer more often ischemic stroke than HIV-seronegative patients.
Conclusions: Mild stroke and male gender were associated with favourable outcome. HIV-infection is common in stroke
patients in Malawi but does not worsen the outcome of stroke. However, it may be a risk factor for ischemic stroke for
young people, who do not have the common stroke risk factors. Our results are significant, because stroke outcome in HIV-
seropositive patients has not been studied before in a setting such as ours, with very limited resources and a high
prevalence of HIV.
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Introduction
In developing countries the number of disability-adjusted life
years caused by cerebrovascular disease is more than six times
higher than in high-income countries: More than 85% of all stroke
deaths occurs in low-income countries [1].
There is a paucity of data on the outcome of stroke in sub-
Saharan Africa. Only two reports are available, both from West
Africa. One-year case-fatality of stroke in the Gambia and Senegal
was 62% and 50% respectively. In the Gambia hospital mortality
following a stroke was 41% [2,3]. Both of these countries have a
relatively low HIV-1 prevalence. Malawi, like many of its
neighbours, has a high HIV-1 prevalence. HIV-infected stroke
patients present more often with cryptogenic strokes compared to
HIV-seronegative individuals [4–6]. In a South African study, one
third of HIV-1-infected patients, presenting with a stroke, had a
recent or current opportunistic infection [7].
Malawi is situated in Central-Southern Africa (Figure 1).
According to the Human Development Index, Malawi is among
the countries with low human development, ranking 171 out of
187 countries [8]. Malawi has a population of 13.2 million. The
life expectancy is 53 years for men and 54 years for women.
Infectious diseases are still the main cause of mortality, but non-
communicable diseases are estimated to account for 28% of all
deaths [9]. 12% of the population aged 15–49 has HIV/AIDS.
Mortality from stroke was over 7200 in 2002 [10]. A previous
survey found that the seroprevalence of HIV among stroke
inpatients at a central hospital in Malawi was 48% [4]. Malawi has
a national programme for providing Highly Active Antiretroviral
Treatment (HAART) free for HIV- infected patients. At the time
of this study first-line treatment was a combination of three drugs:
nevirapine, stavudine and lamivudine [11].
The primary aim of this study was to determine the functional
outcome of first-ever acute stroke at one year of follow-up.
Secondary aims were to describe the one-year mortality of stroke
and to determine the effect of baseline demographics, including
presence of HIV-infection.
Methods
This was a prospective study of patients presenting with a first-
ever acute stroke to the Queen Elizabeth Central Hospital
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(QECH) in Blantyre. QECH is the largest hospital in Malawi. It
provides all levels of care, from primary to tertiary to patients
within Southern Malawi. The QECH is the only public hospital
within Blantyre District. Blantyre has a population of 1 million. It
is the second largest city in Malawi after the capital city, Lilongwe
(figure 1) [12].
The study recruitment took place between February 2008 and
April 2009.
Objectives
The objectives were to determine the functional outcome of
first-ever acute stroke and to determine the effect of baseline
demographics in Malawi, a sub-Saharan African country with
high HIV-prevalence.
Participants
Patients were eligible for the study if, they were 18 years or
older, had a first-ever acute stroke (0–7 days before admission),
and lived within 100 km of QECH. The diagnosis of stroke was
based on clinical findings, according to WHO recommendations
[13]. Patients with previous stroke-like symptoms, head trauma or
other central nervous system (CNS) diagnoses were excluded from
the study. Baseline assessment was carried out within 72 hours of
admission.
Description of Procedures or Investigations undertaken
Using information from the patient, their guardian and the
patient’s hand-held health record, demographic details, past
medical history and medication use were recorded. If age was
unknown it was estimated, within 5 years, by asking the patient’s
life history and age of their children. Current cigarette smoking
and heavy alcohol use (estimated .100 g/day) were recorded.
Study clinicians DC or TH carried out clinical examination. This
included a detailed cardiovascular and neurological examination.
The Mid Upper Arm Circumference (MUAC) was used to
estimate nutritional status. Serum total, random cholesterol, full
blood count, random or fasting capillary blood glucose (On Call
PlusH glucometer), rapid plasma reagin-test to screen for syphilis
(RPR), and presence of HIV-infection using two standard rapid
immunoassays (Uni-GoldTM RecombigenH HIV and DetermineH
HIV-1/2) were measured. If the HIV-test was reactive the WHO
HIV clinical stage was recorded [14] and serum CD4-count
(FACS Count, Becton, Dickinson, San Jose, CA) was measured.
Brain imaging was done by computed tomography-scan (CT,
Philips single slice CT scanner, TOMOSCAN EG, Netherlands)
or magnet resonance-imaging scan (MRI, 0.35T General Electric
Signa Ovation excite with open configuration, China).
WHO definitions were used for hypertension, diabetes mellitus
and hypercholesterolemia [15,16]. MUAC#23 cm was consid-
ered underweight and $33 cm obese [17].
Stroke severity at recruitment was assessed by the National
Institute of Health Stroke Scale (NIHSS) [18]. This was modified;
because people do not always know their age, the name of the
current president of Malawi was asked instead (mNIHSS).
mNIHSS 0–6 was considered mild, 7–12 moderate, 13–20 severe,
$21 very severe stroke. The clinical subtype of stroke was
recorded according to the classification of Bamford [19]. The
modified Rankin scale (mRS) was evaluated from the history
before the onset of stroke and by the clinical findings at the time of
recruitment [20]: mRS 0–2 was considered good, mRS 3 fair, and
4–6 poor outcome.
Patients were followed up 6–8 weeks, six months and one year
from stroke onset. At follow-up new health events, blood pressure
and mRS were recorded. If possible, follow-up was done at a
designated clinic at QECH. For patients who were unable to
attend clinic a home visit was carried out. Alternatively the
patients or their guardians were contacted by phone and the mRS
was done based on information given.
Ethics
The Malawi College of Medicine Research Ethical Committee
(COMREC P 07/07/573) granted approval for the study. The
patients, or, in case of reduced consciousness or severe dysphasia,
the guardians, gave consent.
Statistical methods
The primary outcome measure was mRS-score at one year,
comparing a good/fair outcome (mRS 0–3) to a poor outcome
(mRS 4–6). Data were analysed using StatviewTM and STATATM
for multivariate analysis. Descriptive statistics (mean, SD) were
used to describe the baseline data. Proportions were compared by
X2 test and means by Student’s t test, for normally distributed
data, and Kruskal-Wallis test for non-parametric data.
Results
One hundred and fifty patients were recruited. Brain imaging
was available in 127: 124 patients had CT and 3 had MRI. Three
patients were excluded from analysis as their brain imaging or
follow-up suggested probable malignancy, so the final sample was
147 (figure 2).
Baseline characteristics (table 1) and etiological factors
The mean (6SD) age was 54.2 (616.9) years, 47.7% were
female. Hypertension, diabetes and hypercholesterolemia were
present in 55.0%, 21.0% and 15.0%, respectively. Twenty-six
(17.7%) admitted smoking tobacco and 22 (15.0%) were heavy
alcohol drinkers. Fifty (34.0%) of patients were HIV-seropositive.
They were significantly younger (39.8612.4 vs 61.9614.0 years,
Figure 1. Map of Malawi in Africa. (source: http://www.un.org/
depts/Cartographic/map/profile/malawi.pdf).
doi:10.1371/journal.pone.0033765.g001
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p,0.0001), had lower haemoglobin levels (11.865.8 vs
13.662.5 g/dL, p = 0.0003), and were less likely to have stroke
risk factors of hypertension (75.3% vs 24.0%, p,0.0001), and
diabetes (25.0% vs 6.0%, p= 0.004). There was a strong
relationship between age at the time of first ever stroke, and
HIV-status; 65.2% of those aged,55 years were HIV-seropositive
whereas only 10.3% of those .55 years were HIV-seropositive
(X2= 43.1, p,0.0001). In those who were HIV-seropositive the
WHO clinical staging was 1 or 2 in 39 (78.0%). Despite this, 28/
35 in whom results were available, had CD4 cell counts of ,300
cells/ml. Eleven subjects were taking HAART. Six had started
HAART within the past 6 months, the remainder had been taking
HAART for at least one year, however, three out of five patients
with long term HAART use had CD4 ,100 cells/ml, suggesting a
possibility of HAART-failure. 100 patients had an ECG, of whom
only 7 had atrial fibrillation (AF). The mean age of AF cases was
65.9612 years and 4/7 were HIV-seropositive. Fifteen subjects
had a reactive RPR suggesting syphilis infection, five of these were
HIV-seropositive.
Type of stroke, pre-stroke function and stroke severity
Thirty-two (32/124, 25.8%) scans showed intracerebral hem-
orrhage (ICH). The remainder were consistent with cerebral
infarction (figure 2). ICH was associated with hypertension; 87.5%
vs. 46.7% were hypertensive, (X2= 15.4, p,0.0001) and was less
common in HIV-seropositive patients (11.1% vs 34.7%, X2= 8.1,
p = 0.004). Multiple logistic regression controlling for age, gender
and other vascular risk factors showed that hypertension and HIV-
Figure 2. Study flow chart with CT/MRI-scan findings and outcome. pt/s = patient/s, WHO=world health organisation, CT/MRI =Computed
tomography or magnetic resonance imaging, mRS=modified Rankin scale.
doi:10.1371/journal.pone.0033765.g002
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status were independently associated with the type of stroke; For
ICH and hypertension (OR 6.7 95%CI 1.3–35.2, p = 0.024) for
HIV-seropositive and ischemic stroke (OR 4.5 95%CI 1.03–20.4,
p = 0.046). The clinical subtypes, pre-stroke functional status
(mRS) and stroke severity (mNIHSS) are presented in table 1. The
commonest stroke syndrome was partial anterior circulation
(PACS). 36.1% had left hemiparesis. The vast majority of subjects
were fully independent before their stroke and mRS did not vary
with age, gender or HIV-status. On admission 83 (56.5%) had
severe strokes (mNIHSS $13). Stroke severity was associated with
older age (mNIHSS $13 59.2615.5 vs 48.5616.9 years,
p,0.0001), but not with gender or HIV-status. In multiple logistic
regression none of these variables were significantly, independently
associated with stroke severity.
Stroke outcomes
Thirty-three patients (22.4%) died in hospital. Outcome at 1-year
was unavailable on 16 subjects. Cumulative mortality rates at 6
weeks, 6 months, and 1-year were 37/134 (27.6%), 52/134 (38.8%),
and 59/131 (45.0%), (see table 2). Mortality at 1-year was
significantly related to older age (58.5616.6 vs. 54.1615.4 years,
p=0.013), female gender (55% females vs 36.6% male, X2=4.4,
p=0.035) and stroke severity on admission (mNIHSS$13, 60.3%
mortality vs. mNIHSS 0–12, 22.6% mortality, X2=18.0,
p,0.0001), but not HIV. High mNIHSS score at presentation
(mNIHSS $13) did not relate to type of stroke, hemorrhagic or
ischemic (X2=2, p=0.15). In multiple logistic regression
mNIHSS$13 at presentation (OR 41 95%CI 1.2–14.3, p=0.024)
and female gender (OR 3.8 95%CI 1.4–10.3, p=0.008) were
independent determinants of mortality at one year.
The functional outcome (mRS) at 6 weeks, 6 months and 1 year
are shown in table 2. At one year 61/131 (46.6%) hadmRS 0–3, and
70/131 (53.4%) had mRS 4–6. Poor outcome was associated with
older age; (58.8616.6 vs 52.6615.2 years, p= 0.027), female gender;
62.3% of women vs 45.1% of men, (X2=3.9, p=0.048), and more
severe stroke, mNIHSS$13, at presentation (X2=35.9, p,0.0001),
but not with HIV-status. In multiple logistic regression mNIHSS
$13 at presentation (OR 4.5 95%CI 1.7–11.8, p= 0.002), and
female gender (OR 2.3 95%CI 1.0–5.5, p=0.05) were independent
determinants of a poor outcome (mRS 4–6) at 1 year.
Post-stroke care
The average length of hospital stay was 15.7610.7 days.
Twenty-nine (19.7%) patients were transferred to a residential
Table 1. Baseline clinical features.
Catecory Subcategory
HIV-negative
N=84
HIV-positive
N=50
HIV unknown
N=13
Total
N=147
P for comparison HIV-positive
vs HIV-negative
Age years (mean SD) 61.9 (14.0) 39.8 (12.4) 63.6 (10.5) 54.2 (16.9) ,0.0001
Female (%) 40 (46.5) 26 (52.0) 5 (38.5) 71 (47.7) 0.54
Hypertensive (n, %) 61 (75.3) 12 (24.0) 10 (77.0) 84 (55.0) ,0.0001
Diabetic (n, %) 21 (25.0) 3 (6.0) 6 (46.2) 29 (19.7) 0.004
Smoker (n, %) 16 (19.3) 7 (14.0) 3 (23.1) 26 (17.7) 0.47
Cholesterol .190 mg/dl (n, %) 15 (17.9) 7 (14.0) 0 22 (15.0) 0.54
Haemoglobin g/dL (mean SD) 13.6 (2.5) 11.8 (5.8) 14.0 (2.8) 12.9 (2.6) 0.0003
MUAC cm (n,%) (mean SD) 27.3 (4.2) 26.4 (3.8) 29.8 (5.2) 27.2 (4.2) 0.2
(n, %) $33 6 (7.1) 4 (8.0) 3 (23.1) 13 (8.8)
24–32 62 (73.8) 37 (74.0) 7 (53.8) 106 (72.1)
#23 11 (13.1) 9 (18.0) 0 20 (13.6)
not available 5 (6.0) 0 3 (23.1) 8 (5.4)
Brain scan IS* 47 (55.6) 40 (80.0) 5 (38.5) 92 (62.6) 0.004
ICH 25 (29.8) 5 (10.0) 2 (15.4) 32 (21.8)
not scanned 12 (14.3) 5 (10.0) 6 (46.2) 23 (15.6)
Clinical subtypes TAC 11 (13.1) 1 (2.0) 7 (53.8) 19 (12.9)
PAC 59 (70.2) 35 (70.0) 5 (38.5) 99 (67.3)
LAC 8 (9.5) 11 (22.0) 1 (7.7) 20 (13.6)
POC 6 (7.1) 3 (6.0) 0 9 (6.1)
Pre-stroke functional status mRS 0–2 83 (98.8) 47 (94.0) 13 (100.0) 143 (97.3) 0.46
mRS 3 1 (1.2) 1 (2.0) 0 2 (1.4)
mRS 4–5 0 2 (4.0) 0 2 (1.4)
Stroke severity: n(%) mNIHSS 0–6 14 (16.6) 12 (24.0) 4 (30.8) 30 (20.4) 0.092
mNIHSS 7–12 17 (20.2) 16 (32.0) 1 (7.7) 34 (23.1)
mNIHSS 13–20 24 (28.6) 11 (22.0) 1 (7.7) 36 (24.5)
mNIHSS$21 29 (34.5) 11 (22.0) 7 (53.8) 47 (32.0)
*Includes 4 subjects with normal scans.
IS = ischemic stroke, ICH = Intracerebral hemorrhage, MUAC=Mid Upper Arm Circumference, TAC = total anterior circulation stroke, PAC=partial anterior circulation
stroke, LAC = lacunar stroke, POC=posterior circulation stroke.
doi:10.1371/journal.pone.0033765.t001
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rehabilitation unit. Nine (6.1%) patients received outpatient
physiotherapy. 127 (86.4%) patients were put on ASA (75 mg
once a day). In 20 of these subsequent CT revealed hemorrhage
and the ASA was stopped. Anticoagulants, ACE-inhibitors and
statins are not routinely available so were not considered in the
evaluation. Thirteen patients had another non-fatal stroke during
one-year follow-up. Two patients developed secondary epilepsy
and one patient developed thalamic pain syndrome. One patient
was diagnosed hypertensive during follow-up. Of the HIV-
seropositive patients that were not on HAART previously, 11
started it during the follow-up year.
Discussion
This study describes mortality and functional outcomes in a
group of patients presenting with a first-ever acute stroke in a sub-
Saharan African country with high HIV-prevalence. The
prevalence of HIV-infection was 34%. We used a strict case
definition to identify stroke patients and excluded non-stroke
diagnoses on the basis of the clinical presentation and brain
imaging.
Hypertension was the most prevalent vascular risk factor, and
was present in 55% of patients. Diabetes was present in 21% of
patients. Both of these risk factors were very much clustered in
older patients. A recent survey in Malawian adults, aged 25–64
years, showed the prevalence of raised blood pressure, raised blood
glucose and hypercholesterolemia were 31.6%, 5.6%, and 10.0%
respectively [16]. Thus, the patients presenting with stroke at
QECH, had a much higher prevalence of vascular risk factors than
the general Malawian population, particularly hypertension and
diabetes. Using MUAC as a marker of nutritional status, levels of
obesity were similar to the general population, where 5.5% have a
BMI $30 Kg/m2 [16]. Smoking and excessive drinking are well-
known risk factors for stroke. In our study rates of smoking were
lower than those reported in the general population [16]. The rate
of AF in this population was low at 7%, although higher than that
reported for black Africans with stroke in South Africa [21]. This
may reflect a younger age group in the South African study where
the average age was 51 years. Interestingly, although patients with
AF were in the older age group, 4 out of 7 were HIV-seropositive,
suggesting a possible effect of HIV on the ageing heart.
Fifty (34%) of patients were HIV-seropositive. The average age
of these patients was 39.8 years. They had less often hypertension
and diabetes and more often ischemic stroke. This supports the
proposed suggestion that HIV is a risk factor for ischemic stroke
[22,23]. In many this was the first time they were aware of their
HIV-status and there were no other clinical indicators of
immunosupression. Twenty-two had CD4 counts ,250 cells/mL
and were not on HAART so were eligible to start HAART
according to the Malawi National Programme [11]. Eleven
patients started HAART during the period of follow-up. It is a
concern that 11 patients (50%) that were eligible did not start
HAART, possibly due to mobility problems or lack of under-
standing of the need. Of the eleven patients that were already on
HAART prior the stroke, five had started HAART in the previous
six months, raising the possibility that ischemic stroke could be
part of an immune reconstitution inflammatory syndrome (IRIS)
[24]. The numbers in our study are too small to allow firm
conclusions, but this is an area, which warrants further
investigation. Long term HAART use is associated with increased
cardiovascular risk, which was possibly relevant in some of our
patients [25]. In addition three out of the 5 patients on long term
HAART had CD4 counts ,100 cells/mL, suggesting possible
immunological treatment failure. In these patients the stroke led to
the diagnosis of possible treatment failure.
Table 2. Functional outcome and mortality.
Category Subcategory
HIV-seronegative
N=84
HIV-seropositive
N=50
HIV unknown
N=13
Total
N=147
P for comparison HIV positive
vs HIV negative
mRS at 6 weeks n(%) mRS 0–2 16 (19.0) 15 (30.0) 1 (7.7) 32 (21.8) 0.015
mRS 3 14 (16.6) 12 (24.0) 4 (30.8) 30 (20.4)
mRS 4–5 27 (32.1) 7 (14.0) 0 34 (23.1)
mRS 6 20 (23.8) 9 (18.0) 8 (61.6) 37 (24.5)
Cumulative
deaths
20 9 8 37
Missing data 7 7 0 14
mRS at 6 months n(%) mRS 0–2 29 (34.5) 17 (34.0) 2 (15.4) 48 (32.7) 0.58
mRS 3 11 (13.1) 6 (12.0) 3 (23.1) 20 (13.6)
mRS 4–5 10 (11.9) 3 (6.0) 0 13 (8.8)
mRS 6 7 (8.3) 8 (16.0) 0 15 (10.2)
Cumulative
deaths
27 17 8 52
Missing data 7 7 0 14
mRS at 1 year n(%) mRS 0–2 31 (36.9) 17 (34.0) 2 (15.4) 50 (34.0) 0.29
mRS 3 3 (3.6) 6 (12.0) 2 (15.4) 11 (7.5)
mRS 4–5 10 (11.9) 1 (2.0) 0 11 (7.5)
mRS 6 5 (6.0) 1 (2.0) 1 (7.7) 7 (4.8)
Cumulative
deaths
32 18 9 59
Missing data 8 8 0 16
doi:10.1371/journal.pone.0033765.t002
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One-year outcome data was available on almost 90% of patients
recruited. The main determinants of death, or death and severe
disability at 1-year were severity of stroke on admission, and
gender. A gender difference in favour of men in stroke outcome is
known. In earlier reports this is reported to be due to women being
older, having higher rates of AF, and being less likely to receive
acute treatment [26]. These factors were not true in our study and
there was no difference in severity of stroke between the genders,
however, female patients still had a worse outcome. In Malawi,
women play a key role as carers in vital issues like patient’s food
and fluid intake, hygiene, and mobilisation during the hospital
stay, and at home. It may be that female patients are less likely to
receive such care from their guardians. This and other socio-
demographic factors may have an influence on why female stroke
patients have a worse prognosis in Malawi, and other developing
countries [2]. Differences in in-hospital, and 1-year mortality
compared to the previous study from Malawi [4] and the studies
from Gambia and Senegal may possibly reflect different
recruitment criteria leading to differences in the baseline
characteristics of the subjects, different patterns of co-morbidity,
and possibly differences in post-stroke care [2,3].
Limitations
This study has a few shortcomings. Recruitment was hospital-
based so does not include stroke patients with mild symptoms who
do not present to hospital, or the very severest strokes, who die
before coming to hospital, or are kept at home. At times we were
frustrated by the limitations of our setting. Equipment, particularly
the CT and ECG-machine broke and could not be repaired within
the time frame of the study. Hence, there is some missing data in
these areas.
Conclusions
Patients presenting with stroke in central hospital in Malawi
divided into two populations. Older patients, over 55 years, were
most likely to be HIV-seronegative and have ‘‘traditional’’
vascular risk factors. Younger patients were very likely to be
HIV-seropositive and vascular risk factors were uncommon. This
suggests that HIV-infection could be a risk factor for stroke for
young people without common stroke risk factors. All the patients
received similar post-stroke care, and although there were
differences in functional ability, as reflected by the mRS-score at
presentation, the 1-year outcome was not associated to HIV-status.
The 1-year mortality was 40.1%. 47.6% had a poor outcome
(mRS 4–6). Stroke severity on admission and female gender were
the only two independent factors associated with outcome. It is
also a concern that only half of those with HIV who were eligible
to start HAART did so, during one year of follow up.
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